Galmed Pharmaceuticals
GLMD
$0.40
Share price
-0.42%
Change (1 day)
-90.38%
Change (1 year)
Categories
Galmed Pharmaceuticals (GLMD) - Total debt
Total debt on the balance sheet as of December 2023 : $0.04 M
According to Galmed Pharmaceuticals 's latest financial reports the company's total debt is $0.04 M. A company’s total debt is the sum of all current and non-current debts.
Galmed Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.04 M | -80.79% |
| 2021-12-31 | $0.22 M | 6.02% |
| 2020-12-31 | $0.21 M | -38.64% |
| 2019-12-31 | $0.35 M | |
| 2018-12-31 | $N/A | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $1.84 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | $5 M | 12,095.12% | 🇺🇸 USA |
 Endo International
ENDPQ | $5.08 M | 12,309.76% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.33 B | 821,817.07% | 🇺🇸 USA |
 Catalent CTLT | $5.01 B | 12,229,168.29% | 🇺🇸 USA |